Page last updated: 2024-11-02

pirenzepine and Ischemic Attack, Transient

pirenzepine has been researched along with Ischemic Attack, Transient in 1 studies

Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirata, H1
Ogawa, N1
Haba, K1
Asanuma, M1
Chou, H1
Mori, A1

Other Studies

1 other study available for pirenzepine and Ischemic Attack, Transient

ArticleYear
Effect of propentofylline on ischemia-induced loss of muscarinic cholinergic receptor binding in the gerbil hippocampus.
    Research communications in chemical pathology and pharmacology, 1992, Volume: 75, Issue:3

    Topics: Animals; Anti-Ulcer Agents; Gerbillinae; Hippocampus; Ischemic Attack, Transient; Kinetics; Pirenzep

1992